who reports todayUS earnings, drawn as flowsMy portfolio

← Who reports today · Health Care

How Cigna (CI) makes money: Q2 2026 revenue breakdown

US GAAP · $M · vs Q2 2025 · reported 07/30/2026

The Cigna Group is an American multinational for-profit managed healthcare and insurance company based in Bloomfield, Connecticut. · Wikipedia

More about the company

Cigna's insurance subsidiaries are major providers of medical, dental, disability, life and accident insurance and related products and services, the majority of which are offered through employers and other groups.

Key growth driver: Pharmacy Revenues — the fastest-growing revenue line: $57,172, +7% y/y. · by the Q2 2026 report

How does Cigna make money?

Cigna brought in $71.7 billion of revenue in Q2 2026, up 6.7% year over year. The largest source was Pharmacy Revenues: $57.2 billion, or 80% of the total, followed by Premiums ($9.86B, 14%) and Fees & Other ($4.37B, 6%). Net income for the quarter was $1.66 billion, up 8.4% year over year.

Revenue by source, Q2 2026
  • Pharmacy Revenues$57.2B · 80% · +6.6%
  • Premiums$9.86B · 14% · +7.7%
  • Fees & Other$4.37B · 6% · +5.5%
  • Net Investment Income$272M · 0.4% · +15.3%

Shares of $71.7B total revenue; changes are year over year, as reported. ≈ marks lines derived from disclosed totals. The same flows are drawn in the Sankey chart below.

When is CI’s next earnings date?

Thursday, October 29, 2026estimated

Cigna (CI) has not confirmed the date yet; Oct 29, 2026 is an estimate based on the company's past reporting schedule and may move once the date is announced. Consensus EPS forecast: $7.46 (7 analysts), vs $7.83 in the same quarter last year.

What time does CI report? Usually before market open: the last 4 results releases reached the SEC at 6:16 am, 6:15 am, 6:15 am, 6:15 am ET.

Last report: Jul 30, 2026 (Q2 2026) — broken down in the Sankey chart below. Dates and consensus: Nasdaq / Zacks Investment Research; companies do reschedule. Who else reports this week →

All figures in $M.

Revenue

$71,668

+6.7%

Net income

$1,660

+8.4%

2.3% margin · EPS $6.29

Sankey diagram of CI (Cigna) earnings report for Q2 2026: revenue, costs and profitPharmacy Revenues$57,172 · +6.6%Premiums$9,859 · +7.7%Fees & Other$4,365 · +5.5%Net Investment Income$272 · +15.3%Total Revenues$71,668 · +6.7%Pharmacy, Medical& Operating Costs ≈$69,49897% of revenues — thepass-through riverPretax Income ≈$2,170Income Taxes ≈$510Shareholders' Net Income$1,660 · +8.4%2.3% margin · EPS $6.29

Verdict: a huge-flow, thin-margin quarter working as designed — revenues +7% to $71.7B (pharmacy alone $57.2B), shareholders' net income +8% to $1,660M at a 2.3% net margin; the insurance side (Cigna Healthcare, adjusted pre-tax +17%) did the growing while Evernorth pharmacy profit was flat, and the FY adjusted-EPS outlook was raised to ≥$30.45.

Adjusted income from operations $2.05B ($7.78/share, +9%). Shareholders' equity $161.35/share (+7%). Weighted shares 264M (−1.6% y/y).

Source and notation

≈ marks derived lines: the release discloses revenues and segment adjusted pre-tax income; the full expense statement lives in the 10-Q. Source: Cigna press release 8-K EX-99.1 (SEC EDGAR).

Open the chart as a PNG image ↗ · for sharing and presentations · free to reuse, CC BY 4.0

CI earnings history: past report dates

Jul 30, 2026 Thu6:16 ambefore market openJun 30, 2026$71.7B+7% y/y$6.29+10% y/y
Apr 30, 2026 Thu6:15 ambefore market openMar 31, 2026$68.5B+5% y/y$6.26+29% y/y
Feb 5, 2026 Thu6:15 ambefore market openDec 31, 2025≈$72.5B+10% y/y≈$4.64−7% y/y
Oct 30, 2025 Thu6:15 ambefore market openSep 30, 2025$69.7B+10% y/y$6.98+165% y/y
Jul 31, 2025 Thu6:15 ambefore market openJun 30, 2025$67.2B+11% y/y$5.71+5% y/y
May 2, 2025 Fri6:16 ambefore market openMar 31, 2025$65.5B+14% y/y$4.85
Jan 30, 2025 Thu6:15 ambefore market openDec 31, 2024≈$65.6B+28% y/y≈$5.01+44% y/y
Oct 31, 2024 Thu6:15 ambefore market openSep 30, 2024$63.7B+30% y/y$2.63−45% y/y
How we count

Report date and time — when the company filed its results press release with the SEC (Form 8-K, Item 2.02); the regular session runs 9:30 am – 4:00 pm ET. Revenue and diluted EPS — the company’s XBRL filings, EPS adjusted for stock splits; ≈ — fourth quarter derived as full year minus three quarters. Source: SEC EDGAR.

Cigna: 5-year financials

2025274,9009,2005,9571,611
2024247,1219,4173,4341,567
2023195,2658,5365,1641,450
2022180,5188,4506,7041,384
2021174,0697,9415,3701,341

$ millions, annual 10-K reports on SEC EDGAR (US GAAP).

How we calculate

Figures are the annual report lines as filed, no adjustments. Free cash flow is operating cash flow minus capital expenditures; dividends are cash paid to common shareholders during the year. “—” means the line isn’t in the filing.

Corporate governance

2/2good

How the company treats minority shareholders: 2 — well, 0 — systematically poorly.

More
  • Feb 202610-K FY2025 cover: a single class of common stock; the legal section shows no shareholder disclosure suits or SEC cases. sec.gov ↗
  • Feb 2026Diluted shares 368.4M (2020) → 268.6M (2025), −27%; dividend $4.00 (2021) → $6.04 (2025). data.sec.gov ↗
  • Mar 20262026 proxy: no related-party transactions in 2025. sec.gov ↗

Scoring: 2.0, no deductions: single share class, diluted shares −27% over 5 years, dividend raised from $0.04 to $6.04 and growing, no shareholder suits or SEC cases in 10 years; False Claims Act penalties are industry matters

Share classes
Single class of common stock (NYSE: CI).
Dilution
Diluted shares 368.4M (2020) → 268.6M (2025), −27%; SBC 0.1% of revenue.
Disclosure
Full reporting.
Dividends
Since 2021 the dividend went from $4.00 → $6.04 (2025) per share, raised every year.
Lawsuits & regulators
10-K FY2025: FTC disputes (settled in Feb 2026 with no penalty) and industry investigations; no shareholder suits or SEC cases; the 2002 shareholder suit ($93M, 2007) is older than 10 years and a single episode — does not change the score.
Related parties
No related-party transactions requiring disclosure in 2025 (2026 proxy).

How the score works · checked as of Sep 2026

Cigna (CI) earnings: FAQ

How does Cigna make money?

Cigna brought in $71.7 billion of revenue in Q2 2026, up 6.7% year over year. The largest source was Pharmacy Revenues: $57.2 billion, or 80% of the total, followed by Premiums ($9.86B, 14%) and Fees & Other ($4.37B, 6%). Net income for the quarter was $1.66 billion, up 8.4% year over year.

When is CI's next earnings date?

Cigna (CI) has not confirmed the date yet; Oct 29, 2026 is an estimate based on its past reporting schedule.

What time does CI report earnings?

Cigna usually reports before market open: its latest results release was filed with the SEC at 6:16 am ET on Jul 30, 2026.

When did CI last report earnings?

Cigna reported Q2 2026 results on Jul 30, 2026.

What is the EPS estimate for CI's next earnings?

The consensus EPS forecast is $7.46 (7 analysts), vs $7.83 in the same quarter last year.

Where can I find Cigna's financial statements?

On SEC EDGAR: quarterly reports (10-Q), the annual report (10-K) and earnings releases (8-K). The “Verified” badge next to the chart links to CI's filings; this page breaks the latest report down in a Sankey chart.

What was CI's net income in Q2 2026?

Cigna reported net income of $1,660M for Q2 2026 (+8.4% year over year), under US GAAP.

Does Cigna pay dividends?

Yes. In 2025, Cigna paid $1,611M in dividends on its common stock, per its 10-K. Earlier years are in the five-year table above.

New to earnings reports? Start with how to read an earnings report.

How this page was made: the figures come from the company's own report on SEC EDGAR; the summary and nuances were drafted by our model from that report. Figures checked against the filing. How we make the breakdowns · Report an error

More reports: CVS · Q2 2026 · DHR · Q2 2026 · ELV · Q2 2026 · GILD · Q2 2026 · HCA · Q2 2026 · ISRG · Q2 2026 · JNJ · Q2 2026 · LLY · Q2 2026 · MCK · Q1 FY2027 · MDT · Q1 2027 · all reports

We use cookies the site needs to work and, with your consent, Google Analytics for visit statistics. Details are in our privacy policy.